Presentation
19 June 2024 Improving cancer photoimmunotherapy: Integrating targeted nanotechnology, a clinical laser microendoscopy, and fluorescence-guided intervention
Author Affiliations +
Abstract
Advanced-stage ovarian cancer becomes extremely challenging to treat effectively using current surgical and chemotherapy methods due to factors such as peritoneal metastasis, incomplete resection, and drug resistance. While photoimmunotherapy is emerging as a promising option for unresectable metastases, its full potential often goes unrealized due to varying treatment outcomes. This research effort aims to enhance the reliability, safety, and effectiveness of photoimmunotherapy for peritoneal metastases by combining targeted nanotechnology, fluorescence-guided intervention, and a state-of-the-art medical laser system.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Huang-Chiao Huang, Barry J. Liang, Sumiao Pang, Robert Perttila, Chen-Hua Ma, Payal Srivastava, Brandon Gaitan, Aaron Sorrin, Nada Fadul, Idrisa Rahmana, Zoe Ylöniemi, Dana M. Roque, Tayyaba Hasan, and Petteri Uusimaa "Improving cancer photoimmunotherapy: Integrating targeted nanotechnology, a clinical laser microendoscopy, and fluorescence-guided intervention", Proc. SPIE PC13009, Clinical Biophotonics III, PC1300909 (19 June 2024); https://doi.org/10.1117/12.3012419
Advertisement
Advertisement
KEYWORDS
Cancer

Nanotechnology

Photoimmunotherapy

Animal model studies

Chemotherapy

Mouse models

Ovarian cancer

Back to Top